---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-026349"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2024-07-05T23:59:59+00:00"
generated_at: "2026-05-31T23:21:04.042556+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BriaCell receives Nasdaq notice for failing $35M minimum MVLS requirement

## Summary
- Received Nasdaq letter on July 3, 2024, for MVLS below $35M for 33 consecutive business days.
- Has until December 30, 2024 (180-day compliance period) to regain compliance.
- To regain compliance, MVLS must close at $35M+ for at least 10 consecutive business days.
- Failure could lead to delisting, with appeal rights to a Nasdaq Hearings Panel.
- Listing continues pending compliance; no immediate impact on trading.

## SEC filing metadata
- accession: 0001493152-24-026349
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2024-07-05T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315224026349/0001493152-24-026349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315224026349/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-026349
- JSON: https://secwatch.observer/filing/0001493152-24-026349.json
- Plain text: https://secwatch.observer/filing/0001493152-24-026349.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.